You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AKTS Sale Disclosure
Herrmann Ken · SEC Form 4 · Filed Jul 21, 2026
Sale
Calculated transaction value
$86.12K
Herrmann Ken Director
AKTS
Aktis Oncology, Inc.
AKTS
Transaction date
Jul 20, 2026
Public filing date
Jul 21, 2026
Filing lag
Filed 1 day later
AKTS daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,506 shares @ $24.56
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-310991
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$122.13K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aktis Oncology, Inc. AKTS | Exercise | Jul 20, 2026 | $0 |
| Aktis Oncology, Inc. AKTS | Sale | Jul 20, 2026 | $33.16K |
| Aktis Oncology, Inc. AKTS Current | Sale | Jul 20, 2026 | $86.12K |
| Aktis Oncology, Inc. AKTS | Exercise | Jul 20, 2026 | $280.48 |
| Aktis Oncology, Inc. AKTS | Exercise | Jul 20, 2026 | $2.58K |
| Aktis Oncology, Inc. AKTS | Exercise | Jul 20, 2026 | $0 |